GT
Greenleaf Trust Portfolio holdings
AUM
$11.3B
1-Year Return
16.87%
This Quarter Return
+22.46%
1 Year Return
+16.87%
3 Year Return
+90.17%
5 Year Return
+122.83%
10 Year Return
+313.46%
AUM
$6.07B
AUM Growth
+$1.01B
(+20%)
Cap. Flow
-$79.3M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
86.37%
Holding
568
New
78
Increased
207
Reduced
198
Closed
43
Top Buys
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$12.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$9.05M |
| 3 |
Microsoft
MSFT
|
+$6.02M |
| 4 |
IQ ARB Merger Arbitrage ETF
MNA
|
+$4.72M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
+$4.45M |
Top Sells
| 1 |
Stryker
SYK
|
+$78.6M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$30.2M |
| 3 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$9.63M |
| 4 |
Hologic
HOLX
|
+$4.87M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.01M |
Sector Composition
| 1 | Healthcare | 74.1% |
| 2 | Technology | 2.26% |
| 3 | Financials | 2.14% |
| 4 | Consumer Discretionary | 1.36% |
| 5 | Consumer Staples | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAJ
351
DELISTED
Canon, Inc.
CAJ
| $345K | 0.01% |
11,885
-3,386
| -22% | -$98.3K |
|
352
Navient
NAVI
$1.35B
| $344K | 0.01% |
+29,731
| New | +$344K |
|
353
VeriSign
VRSN
$26.4B
| $344K | 0.01% |
1,895
-3,493
| -65% | -$634K |
|
|
AGN
354
DELISTED
Allergan plc
AGN
| $344K | 0.01% |
2,349
+384
| +20% | +$56.2K |
|
355
iShares US Technology ETF
IYW
$23.2B
| $342K | 0.01% |
+7,172
| New | +$342K |
|
356
Bank OZK
OZK
$5.92B
| $342K | 0.01% |
11,800
-2,222
| -16% | -$64.4K |
|
357
Verisk Analytics
VRSK
$38.1B
| $341K | 0.01% |
2,563
+121
| +5% | +$16.1K |
|
358
Magna International
MGA
$13B
| $337K | 0.01% |
6,917
+212
| +3% | +$10.3K |
|
359
Oneok
OKE
$44.9B
| $336K | 0.01% |
4,817
+67
| +1% | +$4.67K |
|
360
RELX
RELX
$86.4B
| $336K | 0.01% |
15,678
+3,197
| +26% | +$68.5K |
|
361
Ryder
R
$7.67B
| $334K | 0.01% |
+5,383
| New | +$334K |
|
362
W.P. Carey
WPC
$14.7B
| $333K | 0.01% |
4,337
+25
| +0.6% | +$1.92K |
|
363
Dr. Reddy's Laboratories
RDY
$11.9B
| $331K | 0.01% |
40,915
-13,830
| -25% | -$112K |
|
364
Takeda Pharmaceutical
TAK
$48.2B
| $331K | 0.01% |
+16,254
| New | +$331K |
|
365
Wipro
WIT
$28.8B
| $327K | 0.01% |
164,232
-15,293
| -9% | -$30.5K |
|
366
DTE Energy
DTE
$28B
| $326K | 0.01% |
3,074
-292
| -9% | -$31K |
|
367
CME Group
CME
$94.6B
| $325K | 0.01% |
1,976
-650
| -25% | -$107K |
|
|
CIM
368
Chimera Investment
CIM
$1.19B
| $322K | 0.01% |
5,723
| – | – |
|
369
Mitsubishi UFJ Financial
MUFG
$177B
| $320K | 0.01% |
64,689
+13,856
| +27% | +$68.5K |
|
370
MetLife
MET
$52.9B
| $317K | 0.01% |
7,453
+35
| +0.5% | +$1.49K |
|
371
CRH
CRH
$75.2B
| $312K | 0.01% |
10,066
-2,466
| -20% | -$76.4K |
|
372
CGI
GIB
$21.5B
| $312K | 0.01% |
4,531
-11,806
| -72% | -$813K |
|
373
NXP Semiconductors
NXPI
$56.9B
| $312K | 0.01% |
3,525
-1,449
| -29% | -$128K |
|
|
DFS
374
DELISTED
Discover Financial Services
DFS
| $306K | 0.01% |
4,300
+10
| +0.2% | +$712 |
|
375
Parker-Hannifin
PH
$96.3B
| $306K | 0.01% |
+1,782
| New | +$306K |
|